Standard BioTools
LAB
LAB
86 hedge funds and large institutions have $70.2M invested in Standard BioTools in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
61% less capital invested
Capital invested by funds: $179M → $70.2M (-$109M)
69% less call options, than puts
Call options by funds: $109K | Put options by funds: $352K
Holders
86
Holding in Top 10
–
Calls
$109K
Puts
$352K
Top Buyers
| 1 | +$3.18M | |
| 2 | +$1.82M | |
| 3 | +$1.06M | |
| 4 |
E
Ergoteles
New York
|
+$557K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$333K |
Top Sellers
| 1 | -$6.64M | |
| 2 | -$5.87M | |
| 3 | -$3.52M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.93M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.05M |